2022 Nebraska Revised Statutes
Chapter 71 - Public Health and Welfare
71-9603 - Eligible patient.
71-9603. Eligible patient.
To be an eligible patient under the Investigational Drug Use Act, a person shall:
(1) Have an advanced illness, attested by the person's treating physician;
(2) Have considered all other treatment options approved by the United States Food and Drug Administration at the time;
(3) Have a recommendation from his or her treating physician for an investigational drug, biological product, or device;
(4) Give written, informed consent for the use of the investigational drug, biological product, or device;
(5) Have documentation from his or her treating physician that he or she meets the requirements of the act; and
(6) Not be a patient receiving inpatient treatment in a hospital licensed pursuant to the Health Care Facility Licensure Act.
Source
- Laws 2018, LB117, ยง 3.
Cross References
- Health Care Facility Licensure Act, see section 71-401.
